Biosimilars; a unique opportunity for Iran national health sector and national pharmaceutical industry

Journal Title: DARU Journal of Pharmaceutical Sciences - Year 2012, Vol 20, Issue 0

Abstract

In 1980s, medicines produced through recombinant DNA technology created a novel opportunity for management of several debilitating and life threatening diseases. However, these medicines are very expensive and therefore not affordable for many patients especially those living in low resourced countries. Biopharmaceuticals mostly have a high unit cost and often prescribed for chronic medical conditions with possibility of long-term use.

Authors and Affiliations

Abdol Majid Cheraghali

Keywords

Related Articles

Synthesis and antibacterial activity of novel levofloxacin derivatives containing a substituted thienylethyl moiety

Background and the purpose of the study Piperazinyl quinolones such as ciprofloxacin, ofloxacin and levofloxacin are an important group of quinolone antimicrobials which are widely used in the treatment of various infect...

The effect of Camellia Sinensis (green tea) mouthwash on plaque-induced gingivitis: a single-blinded randomized controlled clinical trial

Background and the purpose of the Study Complementary medicine received high attention during last decades. We aimed to assess the efficacy of Green tea mouthwash on plaque-induced gingivitis as the most common form of...

A survey of poison control centers worldwide

To stem the rising incidence of toxic exposure as well as the associated morbidity and mortality, the past century has seen the establishment and evolution of poison control centers (PCCs) worldwide. Depending on the loc...

Development and characterization of chitosan-polycarbophil interpolyelectrolyte complex-based 5-flurouracil formulations for buccal, vaginal and rectal application

The present investigation was designed with the intention to formulate versatile 5-flurouracil (5-FU) matrix tablet that fulfills the therapeutic needs that are lacking in current cancer treatment and aimed at minimizing...

Comparison of hypertonic saline versus normal saline on cytokine profile during CABG

Background and the purpose of the study Blood contact with artificial surfaces of the extracorporeal circuit and ischemia-reperfusion injury in CABG with CPB, may lead to a systemic inflammatory response. Hypertonic sali...

Download PDF file
  • EP ID EP150956
  • DOI -
  • Views 93
  • Downloads 0

How To Cite

Abdol Majid Cheraghali (2012). Biosimilars; a unique opportunity for Iran national health sector and national pharmaceutical industry. DARU Journal of Pharmaceutical Sciences, 20(0), 1-8. https://europub.co.uk/articles/-A-150956